Ignite Creation Date:
2025-12-24 @ 11:45 AM
Ignite Modification Date:
2025-12-29 @ 3:42 AM
Study NCT ID:
NCT05661461
Status:
RECRUITING
Last Update Posted:
2025-11-13
First Post:
2022-12-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment
Sponsor:
Aadi Bioscience, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-11-23
Start Date Type:
ACTUAL
Primary Completion Date:
2026-06-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-08-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-12-14
First Submit QC Date:
None
Study First Post Date:
2022-12-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-12
Last Update Post Date:
2025-11-13
Last Update Post Date Type:
ESTIMATED